{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:45:37Z","timestamp":1783111537239,"version":"3.54.6"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/nrneurol.2015.143","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T10:17:23Z","timestamp":1440497843000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Type I interferon dysregulation and neurological disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Sarah","family":"McGlasson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Jury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"BFnrneurol2015143_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 258\u2013267 (1957).","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"BFnrneurol2015143_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1098\/rspb.1957.0049","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs, A., Lindenmann, J. & Valentine, R. C. Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 268\u2013273 (1957).","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"BFnrneurol2015143_CR3","first-page":"750","volume":"148","author":"Y Nagano","year":"1954","unstructured":"Nagano, Y., Kojima, Y. & Sawai, Y. Immunity and interference in vaccinia; inhibition of skin infection by inactivated virus [French]. C. R. Seances Soc. Biol. Fil. 148, 750\u2013752 (1954).","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"BFnrneurol2015143_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1126\/science.149.3681.310","volume":"149","author":"EF Wheelock","year":"1965","unstructured":"Wheelock, E. F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310\u2013311 (1965).","journal-title":"Science"},{"key":"BFnrneurol2015143_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1073\/pnas.58.3.1004","volume":"58","author":"AK Field","year":"1967","unstructured":"Field, A. K., Tytell, A. A., Lampson, G. P. & Hilleman, M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl Acad. Sci. USA 58, 1004\u20131010 (1967).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2015143_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","volume":"1238","author":"YJ Crow","year":"2011","unstructured":"Crow, Y. J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci. 1238, 91\u201398 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnrneurol2015143_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0888-7543(05)80238-1","volume":"14","author":"OI Olopade","year":"1992","unstructured":"Olopade, O. I. et al. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14, 437\u2013443 (1992).","journal-title":"Genomics"},{"key":"BFnrneurol2015143_CR8","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1128\/JVI.77.3.1992-2002.2003","volume":"77","author":"SM Altmann","year":"2003","unstructured":"Altmann, S. M., Mellon, M. T., Distel, D. L. & Kim, C. H. Molecular and functional analysis of an interferon gene from the zebrafish, Danio rerio. J. Virol. 77, 1992\u20132002 (2003).","journal-title":"J. Virol."},{"key":"BFnrneurol2015143_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/107999003322485107","volume":"23","author":"B Robertsen","year":"2003","unstructured":"Robertsen, B., Bergan, V., Rokenes, T., Larsen, R. & Albuquerque, A. Atlantic salmon interferon genes: cloning, sequence analysis, expression, and biological activity. J. Interferon Cytokine Res. 23, 601\u2013612 (2003).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrneurol2015143_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13238-013-3021-1","volume":"4","author":"L Xu","year":"2013","unstructured":"Xu, L., Yang, L. & Liu, W. Distinct evolution process among type I interferon in mammals. Protein Cell 4, 383\u2013392 (2013).","journal-title":"Protein Cell"},{"key":"BFnrneurol2015143_CR11","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","volume":"170","author":"M Kerkmann","year":"2003","unstructured":"Kerkmann, M. et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170, 4465\u20134474 (2003).","journal-title":"J. Immunol."},{"key":"BFnrneurol2015143_CR12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1189\/jlb.72.5.1011","volume":"72","author":"R Takauji","year":"2002","unstructured":"Takauji, R. et al. CpG-DNA-induced IFN-\u03b1 production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72, 1011\u20131019 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneurol2015143_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1189\/jlb.0603255","volume":"74","author":"A Izaguirre","year":"2003","unstructured":"Izaguirre, A. et al. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74, 1125\u20131138 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrneurol2015143_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri3247","volume":"12","author":"CJ Desmet","year":"2012","unstructured":"Desmet, C. J. & Ishii, K. J. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat. Rev. Immunol. 12, 479\u2013491 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneurol2015143_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1126\/science.1220363","volume":"337","author":"M Oldenburg","year":"2012","unstructured":"Oldenburg, M. et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337, 1111\u20131115 (2012).","journal-title":"Science"},{"key":"BFnrneurol2015143_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/embj.201386117","volume":"33","author":"RE Rigby","year":"2014","unstructured":"Rigby, R. E. et al. RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J. 33, 542\u2013558 (2014).","journal-title":"EMBO J."},{"key":"BFnrneurol2015143_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrneurol2015143_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"45 5","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 45 5, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788\u2013792 (2009).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR20","doi-asserted-by":"publisher","first-page":"20053","DOI":"10.1074\/jbc.R700006200","volume":"282","author":"NA de Weerd","year":"2007","unstructured":"de Weerd, N. A., Samarajiwa, S. A. & Hertzog, P. J. Type I interferon receptors: biochemistry and biological functions. J. Biol. Chem. 282, 20053\u201320057 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2015143_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","volume":"25","author":"AH van Boxel-Dezaire","year":"2006","unstructured":"van Boxel-Dezaire, A. H., Rani, M. R. & Stark, G. R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361\u2013372 (2006).","journal-title":"Immunity"},{"key":"BFnrneurol2015143_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. & Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519\u2013525 (2011).","journal-title":"Curr. Opin. Virol."},{"key":"BFnrneurol2015143_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481\u2013485 (2011).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15252\/embr.201439366","volume":"16","author":"F Ma","year":"2015","unstructured":"Ma, F. et al. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. EMBO Rep. 16, 202\u2013212 (2015).","journal-title":"EMBO Rep."},{"key":"BFnrneurol2015143_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1128\/JVI.01650-07","volume":"82","author":"M-J Kim","year":"2008","unstructured":"Kim, M.-J., Hwang, S.-Y., Imaizumi, T. & Yoo, J.-Y. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82, 1474\u20131483 (2008).","journal-title":"J. Virol."},{"key":"BFnrneurol2015143_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0962-8924(93)90055-6","volume":"3","author":"P Staeheli","year":"1993","unstructured":"Staeheli, P., Pitossi, F. & Pavlovic, J. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3, 268\u2013272 (1993).","journal-title":"Trends Cell Biol."},{"key":"BFnrneurol2015143_CR27","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/j.1460-2075.1992.tb05212.x","volume":"11","author":"T Zurcher","year":"1992","unstructured":"Zurcher, T., Pavlovic, J. & Staeheli, P. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 11, 1657\u20131661 (1992).","journal-title":"EMBO J."},{"key":"BFnrneurol2015143_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jir.2010.0076","volume":"31","author":"O Haller","year":"2011","unstructured":"Haller, O. & Kochs, G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 31, 79\u201387 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrneurol2015143_CR29","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1073\/pnas.052430399","volume":"99","author":"G Kochs","year":"2002","unstructured":"Kochs, G., Janzen, C., Hohenberg, H. & Haller, O. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl Acad. Sci. USA 99, 3153\u20133158 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2015143_CR30","doi-asserted-by":"publisher","first-page":"14172","DOI":"10.1074\/jbc.M200244200","volume":"277","author":"G Kochs","year":"2002","unstructured":"Kochs, G., Haener, M., Aebi, U. & Haller, O. Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers. J. Biol. Chem. 277, 14172\u201314176 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2015143_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/j.1600-0854.2004.00219.x","volume":"5","author":"M Reichelt","year":"2004","unstructured":"Reichelt, M., Stertz, S., Krijnse-Locker, J., Haller, O. & Kochs, G. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 5, 772\u2013784 (2004).","journal-title":"Traffic"},{"key":"BFnrneurol2015143_CR32","doi-asserted-by":"publisher","first-page":"D852","DOI":"10.1093\/nar\/gkn732","volume":"37","author":"SA Samarajiwa","year":"2009","unstructured":"Samarajiwa, S. A., Forster, S., Auchettl, K. & Hertzog, P. J. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37, D852\u2013D857 (2009).","journal-title":"Nucleic Acids Res."},{"key":"BFnrneurol2015143_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature11583","volume":"491","author":"FG Lafaille","year":"2012","unstructured":"Lafaille, F. G. et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491, 769\u2013773 (2012).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR34","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921 (1994).","journal-title":"Science"},{"key":"BFnrneurol2015143_CR35","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.4049\/jimmunol.0800596","volume":"18 2","author":"CN Detje","year":"2009","unstructured":"Detje, C. N. et al. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 18 2, 2297\u20132304 (2009).","journal-title":"J. Immunol."},{"key":"BFnrneurol2015143_CR36","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1128\/JVI.02044-14","volume":"89","author":"CN Detje","year":"2015","unstructured":"Detje, C. N. et al. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis. J. Virol. 89, 2731\u20132738 (2015).","journal-title":"J. Virol."},{"key":"BFnrneurol2015143_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0006-8993(99)01328-1","volume":"835","author":"IL Campbell","year":"1999","unstructured":"Campbell, I. L. et al. Structural and functional neuropathology in transgenic mice with CNS expression of IFN-\u03b1. Brain Res. 835, 46\u201361 (1999).","journal-title":"Brain Res."},{"key":"BFnrneurol2015143_CR38","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.161.9.5016","volume":"161","author":"Y Akwa","year":"1998","unstructured":"Akwa, Y. et al. Transgenic expression of IFN-\u03b1 in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161, 5016\u20135026 (1998).","journal-title":"J. Immunol."},{"key":"BFnrneurol2015143_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod, J. et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect. Dis. 10, 835\u2013844 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneurol2015143_CR40","first-page":"55","volume":"17","author":"MG Smith","year":"1941","unstructured":"Smith, M. G., Lennette, E. H. & Reames, H. R. Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am. J. Pathol. 17, 55\u2013681 (1941).","journal-title":"Am. J. Pathol."},{"key":"BFnrneurol2015143_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11940-002-0040-2","volume":"4","author":"RJ Whitley","year":"2002","unstructured":"Whitley, R. J. Herpes simplex virus in children. Curr. Treat. Options Neurol. 4, 231\u2013237 (2002).","journal-title":"Curr. Treat. Options Neurol."},{"key":"BFnrneurol2015143_CR42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/1096-9071(200008)61:4<468::AID-JMV9>3.0.CO;2-9","volume":"61","author":"F Najioullah","year":"2000","unstructured":"Najioullah, F. et al. Diagnosis and surveillance of herpes simplex virus infection of the central nervous system. J. Med. Virol. 61, 468\u2013473 (2000).","journal-title":"J. Med. Virol."},{"key":"BFnrneurol2015143_CR43","first-page":"19","volume":"69","author":"AJ Nahmias","year":"1990","unstructured":"Nahmias, A. J., Lee, F. K. & Beckman-Nahmias, S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. Suppl. 69, 19\u201336 (1990).","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"BFnrneurol2015143_CR44","first-page":"1481","volume":"308","author":"AM Lerner","year":"1983","unstructured":"Lerner, A. M., Levine, D. P. & Reyes, M. P. Two cases of herpes simplex virus encephalitis in the same family. N. Engl. J. Med. 308, 1481 (1983).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015143_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ana.10110","volume":"51","author":"AC Jackson","year":"2002","unstructured":"Jackson, A. C., Melanson, M. & Rossiter, J. P. Familial herpes simplex encephalitis. Ann. Neurol. 51, 406\u2013407 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015143_CR46","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0140-6736(95)92081-1","volume":"346","author":"M Koskiniemi","year":"1995","unstructured":"Koskiniemi, M. et al. Familial herpes encephalitis. Lancet 346, 1553 (1995).","journal-title":"Lancet"},{"key":"BFnrneurol2015143_CR47","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2010.04.020","volume":"157","author":"L Abel","year":"2010","unstructured":"Abel, L. et al. Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J. Pediatr. 157, 623\u2013629, 629.e1 (2010).","journal-title":"J. Pediatr."},{"key":"BFnrneurol2015143_CR48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1097","volume":"33","author":"S Dupuis","year":"2003","unstructured":"Dupuis, S. et al. Impaired response to interferon-\u03b1\/\u03b2 and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388\u2013391 (2003).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR49","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","volume":"116","author":"XF Kong","year":"2010","unstructured":"Kong, X. F. et al. A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Blood 116, 5895\u20135906 (2010).","journal-title":"Blood"},{"key":"BFnrneurol2015143_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1126\/science.1128346","volume":"314","author":"A Casrouge","year":"2006","unstructured":"Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308\u2013312 (2006).","journal-title":"Science"},{"key":"BFnrneurol2015143_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature06726","volume":"452","author":"YM Kim","year":"2008","unstructured":"Kim, Y. M., Brinkmann, M. M., Paquet, M. E. & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452, 234\u2013238 (2008).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR52","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","volume":"31 7","author":"SY Zhang","year":"2007","unstructured":"Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 31 7, 1522\u20131527 (2007).","journal-title":"Science"},{"key":"BFnrneurol2015143_CR53","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1084\/jem.20101568","volume":"208","author":"Y Guo","year":"2011","unstructured":"Guo, Y. et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208, 2083\u20132098 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol2015143_CR54","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich, I. et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 360, 2426\u20132437 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015143_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ana.410150109","volume":"15","author":"J Aicardi","year":"1984","unstructured":"Aicardi, J. & Gouti\u00e8res, F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann. Neurol. 15, 49\u201354 (1984).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2015143_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0022-510X(88)90125-6","volume":"84","author":"P Lebon","year":"1988","unstructured":"Lebon, P. et al. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J. Neurol. Sci. 84, 201\u2013208 (1988).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2015143_CR57","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","volume":"12","author":"GI Rice","year":"2013","unstructured":"Rice, G. I. et al. Assessment of interferon-related biomarkers in Aicardi\u2013Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case\u2013control study. Lancet Neurol. 12, 1159\u20131169 (2013).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2015143_CR58","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ng1845","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow, Y. J. et al. Mutations in the gene encoding the 3\u2032\u20135\u2032 DNA exonuclease TREX1 cause Aicardi\u2013Gouti\u00e8res syndrome at the AGS1 locus. Nat. Genet. 38, 917\u2013920 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR59","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ng1842","volume":"38","author":"YJ Crow","year":"2006","unstructured":"Crow, Y. J. et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi\u2013Gouti\u00e8res syndrome and mimic congenital viral brain infection. Nat. Genet. 38, 910\u2013916 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR60","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng.373","volume":"41","author":"GI Rice","year":"2009","unstructured":"Rice, G. I. et al. Mutations involved in Aicardi\u2013Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41, 829\u2013832 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR61","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature10623","volume":"480","author":"DC Goldstone","year":"2011","unstructured":"Goldstone, D. C. et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480, 379\u2013382 (2011).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR62","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng0806-866","volume":"38","author":"ME Alarcon-Riquelme","year":"2006","unstructured":"Alarcon-Riquelme, M. E. Nucleic acid by-products and chronic inflammation. Nat. Genet. 38, 866\u2013867 (2006).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR63","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/bies.20808","volume":"30","author":"RE Rigby","year":"2008","unstructured":"Rigby, R. E., Leitch, A. & Jackson, A. P. Nucleic acid-mediated inflammatory diseases. Bioessays 30, 833\u20138 (2008).","journal-title":"Bioessays"},{"key":"BFnrneurol2015143_CR64","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","volume":"13 1","author":"YG Yang","year":"2007","unstructured":"Yang, Y. G., Lindahl, T. & Barnes, D. E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 13 1, 873\u2013886 (2007).","journal-title":"Cell"},{"key":"BFnrneurol2015143_CR65","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ng.2414","volume":"44","author":"GI Rice","year":"2012","unstructured":"Rice, G. I. et al. Mutations in ADAR1 cause Aicardi\u2013Gouti\u00e8res syndrome associated with a type I interferon signature. Nat. Genet. 44, 1243\u20131248 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jmedgenet-2013-102038","volume":"51","author":"JH Livingston","year":"2014","unstructured":"Livingston, J. H. et al. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. J. Med. Genet. 51, 76\u201382 (2014).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol2015143_CR67","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","volume":"9","author":"NM Mannion","year":"2014","unstructured":"Mannion, N. M. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482\u20131494 (2014).","journal-title":"Cell Rep."},{"key":"BFnrneurol2015143_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice, G. I. et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46, 503\u2013509 (2014).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR69","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","volume":"81","author":"G Rice","year":"2007","unstructured":"Rice, G. et al. Clinical and molecular phenotype of Aicardi\u2013Gouti\u00e8res syndrome. Am. J. Hum. Genet. 81, 713\u2013725 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2015143_CR70","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1469-8749.2010.03727.x","volume":"5 2","author":"V Ramesh","year":"2010","unstructured":"Ramesh, V. et al. Intracerebral large artery disease in Aicardi\u2013Gouti\u00e8res syndrome implicates SAMHD1 in vascular homeostasis. Dev. Med. Child Neurol. 5 2, 725\u2013732 (2010).","journal-title":"Dev. Med. Child Neurol."},{"key":"BFnrneurol2015143_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.40.3.183","volume":"4 0","author":"YJ Crow","year":"2003","unstructured":"Crow, Y. J. et al. Cree encephalitis is allelic with Aicardi\u2013Gouti\u00e8res syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J. Med. Genet. 4 0, 183\u2013187 (2003).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol2015143_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation. Nature 517, 89\u201393 (2015).","journal-title":"Nature"},{"key":"BFnrneurol2015143_CR73","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1469-8749.2012.04437.x","volume":"55","author":"JH Livingston","year":"2013","unstructured":"Livingston, J. H., Stivaros, S., van der Knaap, M. S. & Crow, Y. J. Recognizable phenotypes associated with intracranial calcification. Dev. Med. Child Neurol. 55, 46\u201357 (2013).","journal-title":"Dev. Med. Child Neurol."},{"key":"BFnrneurol2015143_CR74","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.15252\/embj.201490791","volume":"34","author":"T Goldmann","year":"2015","unstructured":"Goldmann, T. et al. USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J. 34, 1612\u20131629 (2015).","journal-title":"EMBO J."},{"key":"BFnrneurol2015143_CR75","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513443","volume":"80","author":"G Rice","year":"2007","unstructured":"Rice, G. et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi\u2013Gouti\u00e8res syndrome. Am. J. Hum. Genet. 80, 811\u2013815 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol2015143_CR76","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/ajmg.a.32518","volume":"146A","author":"V Navarro","year":"2008","unstructured":"Navarro, V. et al. Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation. Am. J. Med. Genet. A 146A, 2810\u20132815 (2008).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrneurol2015143_CR77","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ng.748","volume":"43","author":"TA Briggs","year":"2011","unstructured":"Briggs, T. A. et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat. Genet. 43, 127\u2013131 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"37 1","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 37 1, 507\u2013518 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015143_CR79","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia, L., Murphy, G. & Isenberg, D. Systemic lupus erythematosus. Lancet 384, 1878\u20131888 (2014).","journal-title":"Lancet"},{"key":"BFnrneurol2015143_CR80","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","volume":"46","author":"M Botto","year":"2009","unstructured":"Botto, M. et al. Complement in human diseases: Lessons from complement deficiencies. Mol. Immunol. 46, 2774\u20132783 (2009).","journal-title":"Mol. Immunol."},{"key":"BFnrneurol2015143_CR81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","volume":"25","author":"J Banchereau","year":"2006","unstructured":"Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383\u2013392 (2006).","journal-title":"Immunity"},{"key":"BFnrneurol2015143_CR82","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100, 2610\u20132615 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2015143_CR83","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett, L. et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711\u2013723 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol2015143_CR84","doi-asserted-by":"crossref","unstructured":"International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204\u2013210 (2008).","DOI":"10.1038\/ng.81"},{"key":"BFnrneurol2015143_CR85","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228\u20131233 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2000-7492","volume":"31","author":"RC Dale","year":"2000","unstructured":"Dale, R. C., Tang, S. P., Heckmatt, J. Z. & Tatnall, F. M. Familial systemic lupus erythematosus and congenital infection-like syndrome. Neuropediatrics 31, 155\u2013158 (2000).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol2015143_CR87","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1055\/s-2005-873058","volume":"36","author":"C De Laet","year":"2005","unstructured":"De Laet, C. et al. Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi\u2013Gouti\u00e8res syndrome. Neuropediatrics 36, 399\u2013402 (2005).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol2015143_CR88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","volume":"85","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch, M. A. et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. (Berl.) 85, 531\u2013537 (2007).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrneurol2015143_CR89","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ng2091","volume":"39","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3\u2032\u20135\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065\u20131067 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR90","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/gene.2010.73","volume":"12","author":"B Namjou","year":"2011","unstructured":"Namjou, B. et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 12, 270\u2013279 (2011).","journal-title":"Genes Immun."},{"key":"BFnrneurol2015143_CR91","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1136\/ard.2009.114157","volume":"69","author":"B de Vries","year":"2010","unstructured":"de Vries, B. et al. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Ann. Rheum. Dis. 69, 1886\u20131887 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneurol2015143_CR92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1172\/JCI78001","volume":"125","author":"C G\u00fcnther","year":"2015","unstructured":"G\u00fcnther, C. et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J. Clin. Invest. 125, 413\u2013424 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2015143_CR93","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.cell.2012.04.011","volume":"149","author":"MA Reijns","year":"2012","unstructured":"Reijns, M. A. et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149, 1008\u20131022 (2012).","journal-title":"Cell"},{"key":"BFnrneurol2015143_CR94","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","volume":"45","author":"FK Tan","year":"2006","unstructured":"Tan, F. K. et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 45, 694\u2013702 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrneurol2015143_CR95","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s004010051071","volume":"98","author":"PG Barth","year":"1999","unstructured":"Barth, P. G., Walter, A. & van Gelderen, I. Aicardi\u2013Gouti\u00e8res syndrome: a genetic microangiopathy? Acta Neuropathol. 98, 212\u2013216 (1999).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2015143_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/s-2004-830532","volume":"36","author":"M Rasmussen","year":"2005","unstructured":"Rasmussen, M., Skullerud, K., Bakke, S. J., Lebon, P. & Jahnsen, F. L. Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi\u2013Gouti\u00e8res syndrome\u2014report of two sisters. Neuropediatrics 36, 40\u201344 (2005).","journal-title":"Neuropediatrics"},{"key":"BFnrneurol2015143_CR97","first-page":"732","volume":"19","author":"JG Hanly","year":"1992","unstructured":"Hanly, J. G., Walsh, N. M. & Sangalang, V. Brain pathology in systemic lupus erythematosus. J. Rheumatol. 19, 732\u2013741 (1992).","journal-title":"J. Rheumatol."},{"key":"BFnrneurol2015143_CR98","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ng2082","volume":"3 9","author":"A Richards","year":"2007","unstructured":"Richards, A. et al. C-terminal truncations in human 3\u2032\u20135\u2032 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet. 3 9, 1068\u20131070 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2015143_CR99","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/bpa.12178","volume":"24","author":"GR Kolar","year":"2014","unstructured":"Kolar, G. R. et al. Neuropathology and genetics of cerebroretinal vasculopathies. Brain Pathol. 24, 510\u2013518 (2014).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2015143_CR100","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1212\/WNL.0b013e3181f4d7ac","volume":"75","author":"FJ Mateen","year":"2010","unstructured":"Mateen, F. J. et al. Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation. Neurology 75, 1211\u20131213 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol2015143_CR101","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1212\/NXI.0000000000000055","volume":"2","author":"E Schuh","year":"2015","unstructured":"Schuh, E. et al. Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL. Neurol. Neuroimmunol. Neuroinflamm. 2, e55 (2015).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"BFnrneurol2015143_CR102","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1007\/s00415-013-7050-8","volume":"260","author":"N Pelzer","year":"2013","unstructured":"Pelzer, N. et al. Heterozygous TREX1 mutations in early-onset cerebrovascular disease. J. Neurol. 260, 2188\u20132190 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol2015143_CR103","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1093\/ndt\/16.10.2111-a","volume":"16","author":"CC Magee","year":"2001","unstructured":"Magee, C. C. Renal thrombotic microangiopathy induced by interferon-alpha. Nephrol. Dial. Transplant. 16, 2111\u20132112 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneurol2015143_CR104","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1177\/1352458514523692","volume":"2 0","author":"C Larochelle","year":"2014","unstructured":"Larochelle, C. et al. Thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon \u03b2. Mult. Scler. 2 0, 1783\u20131787 (2014).","journal-title":"Mult. Scler."},{"key":"BFnrneurol2015143_CR105","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJMc1316118","volume":"370","author":"D Hunt","year":"2014","unstructured":"Hunt, D. et al. Thrombotic microangiopathy associated with interferon beta. N. Engl. J. Med. 370, 1270\u20131271 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015143_CR106","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","volume":"135","author":"CM Magro","year":"2011","unstructured":"Magro, C. M. et al. Degos disease: a C5b-9\/interferon-\u03b1-mediated endotheliopathy syndrome. Am. J. Clin. Pathol. 135, 599\u2013610 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrneurol2015143_CR107","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. & Manel, N. Aicardi\u2013Gouti\u00e8res syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429\u2013440 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneurol2015143_CR108","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.4049\/jimmunol.1401334","volume":"194","author":"E Cuadrado","year":"2015","unstructured":"Cuadrado, E. et al. Phenotypic variation in Aicardi\u2013Gouti\u00e8res syndrome explained by cell-specific IFN-stimulated gene response and cytokine release. J. Immunol. 194, 3623\u20133633 (2015).","journal-title":"J. Immunol."},{"key":"BFnrneurol2015143_CR109","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/glia.20639","volume":"56","author":"JT van Heteren","year":"2008","unstructured":"van Heteren, J. T. et al. Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in Aicardi\u2013Gouti\u00e8res syndrome. Glia 56, 568\u2013578 (2008).","journal-title":"Glia"},{"key":"BFnrneurol2015143_CR110","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","volume":"134","author":"DB Stetson","year":"2008","unstructured":"Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587\u2013598 (2008).","journal-title":"Cell"},{"key":"BFnrneurol2015143_CR111","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","volume":"36","author":"A Gall","year":"2012","unstructured":"Gall, A. et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120\u2013131 (2012).","journal-title":"Immunity"},{"key":"BFnrneurol2015143_CR112","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1128\/MCB.24.15.6719-6727.2004","volume":"24","author":"M Morita","year":"2004","unstructured":"Morita, M. et al. Gene-targeted mice lacking the Trex1 (DNase III) 3\u2032\u21925\u2032 DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24, 6719\u20136727 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrneurol2015143_CR113","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-4690-8-91","volume":"8","author":"GB Beck-Engeser","year":"2011","unstructured":"Beck-Engeser, G. B., Eilat, D. & Wabl, M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 8, 91 (2011).","journal-title":"Retrovirology"},{"key":"BFnrneurol2015143_CR114","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ni.2872","volume":"15","author":"HE Volkman","year":"2014","unstructured":"Volkman, H. E. & Stetson, D. B. The enemy within: endogenous retroelements and autoimmune disease. Nat. Immunol. 15, 415\u2013422 (2014).","journal-title":"Nat. Immunol."},{"key":"BFnrneurol2015143_CR115","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.37824","volume":"65","author":"M Petri","year":"2013","unstructured":"Petri, M. et al. Sifalimumab, a human anti-interferon-\u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum. 65, 1011\u20131021 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrneurol2015143_CR116","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/ard.2010.144485","volume":"70","author":"JT Merrill","year":"2011","unstructured":"Merrill, J. T. et al. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon \u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann. Rheum. Dis. 70, 1905\u20131913 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneurol2015143_CR117","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.a.36887","volume":"167A","author":"YJ Crow","year":"2015","unstructured":"Crow, Y. J. et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am. J. Med. Genet. A 167A, 296\u2013312 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrneurol2015143_CR118","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(10)70103-4","volume":"9","author":"CH Polman","year":"2010","unstructured":"Polman, C. H. et al. Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurol. 9, 740\u2013750 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2015143_CR119","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.44.2.104","volume":"44","author":"JH Klippel","year":"1985","unstructured":"Klippel, J. H., Carette, S., Preble, O. T., Friedman, R. M. & Grimley, P. M. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus. Ann. Rheum. Dis. 44, 104\u2013108 (1985).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T11:29:11Z","timestamp":1691926151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":119,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFnrneurol2015143"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.143","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]},"assertion":[{"value":"25 August 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}